Preceptis CEO Dave Carey on Hummingbird and Helping Kids Avoid the Trauma of Anesthesia
From DeviceTalks Podcast Network · 00:54:02
Show by DeviceTalks Podcast Network
In this episode of DeviceTalks Weekly, Host Tom Salemi talks with Preceptis Medical CEO Dave Carey about his path from MedTech sales to the corner office. Carey shares lessons from launching disruptive technologies at Boston Scientific, Medtronic, Stryker and Pristine Surgical, including what he looks for when hiring salespeople and what it takes to change established clinical workflows. Carey also explains why his new role at Preceptis is personal. After his daughter experienced emergence delirium following anesthesia for an ear tube procedure, Carey was drawn to Hummingbird, Preceptis’ technology for moving ear tube procedures out of the OR and into the physician’s office without general anesthesia. He explains how Preceptis is working with ENTs, pediatricians and parents to drive adoption and why changing even a five-minute procedure requires more than selling a medical device. For more information, visit https://www.hummingbirdeartubes.com We’ll open the episode with Newmarker’s Newsmakers featuring Mindray, Boston Scientific, Medtronic and Johnson & Johnson MedTech. This episode is sponsored by DeviceTalks Tuesdays Connected Health Series. Register at DeviceTalks.com. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:01:13) - A bit of news from Tom Salemi(00:06:18) - Medtronic hires former Recor CEO to run interventional cardiology group(00:08:15) - Mindray looks to fill hospital ventilator gap left by Philips’ exit(00:09:39) - Medtronic strengthens robotic surgery position with Cornerstone deal, analysts say(00:11:15) - Citi downgrades Boston Scientific as cyberattack recovery compounds competitive pressure(00:14:25) - Johnson & Johnson drops LAA assets following suspended pivotal study(00:17:55) - Keynote Interview: Dave Carey, CEO, Preceptis Medical
More episodes of DeviceTalks Podcast Network
More episodes
- How Zimmer Biomet will use AI and robotics to lighten the load on orthopedic surgeons
- Acting on Evidence and Shaping What Comes Next — Medtronic’s Linnea Burman
- A note from Kayleen, we'll be back next week!
- Prana Surgical’s CEO Wants to Bring a Lumpectomy Approach to Lung Surgery
- After FDA Authorization, J&J’s Robotic Surgery President Looks Ahead to OTTAVA’s Commercial Rollout
- Designing for the Whole Picture — Cala Health’s Deanna Harshbarger
- How the CST Unit Builds With Purpose — Medtronic’s Melaine DiLuzio
- J&J MedTech's Polyphonic Lead Explains Why Surgical Intelligence Is the Next Big Shift in the OR
- Turning Boston Scientific around with CEO Mike Mahoney
- Why Botox worked and the Lap-Band didn't with Allergan CEO David Pyott
PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.